Exactly. I question the motive of the downgrade. This company is ahead of all stem cell companies by a few miles and yet, the downgrade from JP Morgan without any explanation strikes to me as a "hidden agenda" decree.
J.P. Morgan is the depository bank that manages the ADR program on behalf of Mesoblast.
So JP Morgan, what exactly is your agenda?
After the pump..., page-3
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.00 |
Change
0.020(2.04%) |
Mkt cap ! $1.136B | |||
| Open | High | Low | Value | Volume |
| $1.01 | $1.04 | 99.0¢ | $3.700M | 3.652M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 40492 | $1.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 52002 | 55 |
View Market Depth
| Last trade - 14.43pm 16/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |